Keyword: Kite Pharma


Gilead Sciences/Kite

There are many ways to make a misstep when it comes to M&A. Sometimes, not making a move can be as detrimental as making a bad move. And there are those who argue that Gilead did both when it agreed to pick up Kite for $11.9 billion in 2017.